FDA Center for Drug Evaluation and Research. Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. 2000-08. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf.
Zhao Chunjian, Wang Lei, Zu Yuangang, et al. Micronization of Ginkgo biloba extract using supercritical antisolvent process[J]. Powder Technology, 2011, 209(1/3):73.
Sun Z, Ma C H, Yang L, et al. Production of ursolic acid nanoparticles by supercritical antisolvent precipitation[J]. Adv Mater Res, 2011 (233/235):2210.
[10]
Huh K M, Lee S C, Cho Y W, et al. Hydrotrop ic polymermicelle system for delivery of paclitaxel[J]. J Control Release, 2005, 101:5934.
[11]
Sui W P, Yin C Q, Chen Y J, et al. Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin[J]. Colloids Surf B Biointerfaces, 2006, 48:13.
[12]
FENG Baolu, LIH Anwen, ZHOU Mingyao, et al. Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability[J]. J Chin Med Mater, 2011, 34(4):605.
[13]
Matsunaga N, Nakamura K, Yamamoto A, et al. Improvement by solid dispersion of the bioavailability of KRN633, a selective inhibitor of VEGF receptor tyrosine kinase, and identification of its potential therapeutic window[J]. Mol Cancer Ther, 2006, 5(1):80.
[14]
Venkatramana M R, Erika A Z, Valentino J S. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent[J]. J Pharm Sci, 2011, 4(100):1576.
[15]
Wang Z, Deng Y, Sun S, et al. Preparation of hydrophobic drugs cyclodextrin complex by lyophilization monophase solution[J]. Drug Dev Ind Pharm, 2006, 32 (1):73.
Zhang N, Zhang N, She D D, et al. Preparation and evaluation of daidzein loaded self-microemulsifying drug delivery system[J]. Applied Mechanics and Materials, 2011, 140:200.
Kakumanu V K, Arora V,Bansal A K. Investigation of factors responsible for low oral biolavailability of cefpodoxime proxetil[J]. Int J Pharm, 2006, 317(2):155.
Yin Lichen, Ding Jieying, He Chunbai, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery[J]. Biomaterials, 2009, 30:5691.
